 |
ArchiveMorning Spy: Social Networking Stocks Hold Ground As Market Dives (QPSA, SINA, NGLPF, HTM, ARRY, CIG, BSBR, CASC, JOYG, PG, GOOG, TSLA, NMR, SPEXD)Posted by Eric Monte at 10:42AM on June 3rd
The markets were experiencing a sharp sell off in early trading after the nonfarm payrolls report was released. The economy managed to add 54,000 jobs in May, down from 232,000 in April. This is the smallest amount of new payroll…  Merck Hikes Diabetes Exposure Via Acquisition (MRK, JNJ, DEPO, ARRY, MNKD, SPEX, BIOD, AMLN, GNBT, ALKS, LLY, ARNA)Posted by Jason Smith at 11:39AM on December 2nd
Pharmaceutical giant Merck (MRK) agreed to purchase Beverly, Massachusetts-based insulin maker SmartCells for as much as $500 million, boosting the firm’s exposure the diabetes segment, which generated $2.58 billion in 2009 revenue. Miller Tabak portfolio manager Les Funtleyder told Bloomberg, “We… Sharp Rebound for MannKind, Generex (GNBT, MNKD, SPEX, AMLN, NVO, ARRY)Posted by Jason Smith at 1:35PM on March 23rd
Shares of Valencia, California-based Mannkind Corp (MNKD) are rebounding sharply after two days of declines in a recent downtrend spurred by the FDA’s request for additional information related to the company’s Afrezza inhaled insulin. The stock remains off by -10% over… OSI Brushes Off Hostile Bid, Cancer Stocks SurgePosted by Owen Vater at 12:48PM on March 1st
OSI Pharmaceuticals (OSIP) soared by over 50% on Monday after receiving an unsolicited buyout bid from Astellas Pharma (OTC: ALPMY) worth $52 per share. According to a press release this morning, OSI Pharmaceuticals isn’t interested in the $52 per share offer it received… Home Diagnostics Buyout Powers Diabetes Segment (HDIX, ARRY, NVO, GNBT, AMLN, MNKD)Posted by Jason Smith at 12:03PM on February 3rd
Home Diagnositics (HDIX) is soaring today after the company announced a definitive merger agreement with Nipro Corporation. Nipro will pay $11.50 in cash per Home Diagnostics share or $215 million for the company in a two-step acquisition, which is set to… Huge Leaps for Small-Cap Pharma PlaysPosted by Max Magee at 10:04AM on December 15th
Shares of Array BioPharma (ARRY) surged on Tuesday after the small-cap company signed a $60 million deal. Array BioPharma announced this morning that it has entered an agreement with pharmaceutical giant Amgen (NASDASQ: AMGN). Amgen will pay $60 million upfront and additional milestone… |
|
Follow us on
  |
| Home | Find | Research | Track | Register | My Account | Logout | Web site design by LightMix |
| © 2007-2013 Indie research Corp. All rights reserved. |